Sildenafil Tablet, Film Coated
Product Images NDC 59746-434

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 59746-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-100s (100mg 100s)

Label for Sildenafil Tablets, USP 100 mg film-coated tablets by Jubilant Cadista Pharmaceuticals Inc. The label includes dosage form and strength, quantity of 100 tablets, storage instructions, and pharmacist dispensing information. It also displays the NDC 59746-436-01, barcodes, and market information with a Cadista logo.*

FDA Label Image

100mg-30s (100mg 30s)

Sildenafil Tablets, USP 100 mg film-coated tablets in a prescription drug label by Jubilant Cadista Pharmaceuticals Inc. The label indicates 30 tablets per package, with storage instructions and a note to dispense with a patient information sheet. The product is made in India and marketed by Jubilant Cadista Pharmaceuticals Inc., Yardley, PA, USA.*

FDA Label Image

25mg-30s (25mg 30s)

Sildenafil Tablets USP 25 mg film-coated tablets label from Jubilant Cadista Pharmaceuticals Inc. The label indicates a 30-tablet package, with instructions to dispense with patient information sheet. It notes sildenafil citrate as the active ingredient equivalent to 25 mg sildenafil and storage conditions between 20°C to 25°C (68°F to 77°F). Made in India and marketed by Jubilant Cadista Pharmaceuticals Inc., Yardley, PA, USA.*

FDA Label Image

50mg-100s (50mg 100s)

Sildenafil Tablets, USP 50 mg film-coated oral tablets label showing the product name, strength, and quantity of 100 tablets. It includes storage instructions, dispensing precautions, and the labeler Jubilant Cadista Pharmaceuticals Inc. The label also displays barcodes, NDC 59746-435-01, and manufacturer information indicating the product is made in India.*

FDA Label Image

50mg-30s (50mg 30s)

Sildenafil Tablets, USP, 50 mg film-coated oral tablets in a 30 tablet package. The label includes dosage instructions to dispense with patient information, storage conditions, and manufacturer details: Jubilant Cadista Pharmaceuticals Inc.*

FDA Label Image

Fig-6 (Fig 67)

Two bar charts showing the effect of Sildenafil and placebo on maintenance of erection by baseline score. Each chart displays the percentage of patients at endpoint across baseline scores from 0 to 5, with different bars representing scores 0 through 5. The top chart illustrates Sildenafil’s effect, with higher percentages in the higher score categories compared to the placebo chart below.*

FDA Label Image

Fig-7 (Fig 7)

A bar chart displaying the percentage of patients reporting improvement in different treatment groups. The groups shown are Placebo, Sildenafil Tablets 25 mg, Sildenafil Tablets 50 mg, and Sildenafil Tablets 100 mg, with increasing percentages of patient-reported improvement as the Sildenafil dose increases.*

FDA Label Image

Fig01 (Fig01)

A line graph showing systolic blood pressure changes (mmHg) over time (hours) post-dose up to 24 hours, comparing Sildenafil 100 mg and placebo. The graph plots pressure changes from pre-dose to 24 hours with distinct lines for Sildenafil and placebo.*

FDA Label Image

Fig02 (Fig02)

A line graph depicting the change in systolic blood pressure (SBP) over 8 hours after dose administration. The graph compares two groups: Doxazosin plus placebo and Doxazosin plus Sildenafil 25 mg. The y-axis represents change in SBP (mmHg), and the x-axis shows time post dose (hours). Data points illustrate trends in blood pressure changes for both treatment groups over time.*

FDA Label Image

Fig03 (Fig03)

A line graph depicting change in systolic blood pressure (SBP) in mmHg over time post dose (hours). It compares two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, tracking SBP changes from 0 to 8 hours with respective labeled markers.*

FDA Label Image

Fig04 (Fig04)

A line graph showing blood pressure changes in mmHg over time after dosing, comparing Doxazosin with Sildenafil 100 mg versus Doxazosin with placebo. The x-axis represents time after dosing in hours (0 to 8), and the y-axis represents blood pressure in mmHg, ranging from -50 to 40. Two lines represent the treatment groups, illustrating differences in blood pressure response over time.*

FDA Label Image

Fig05 (Fig05)

A pharmacokinetic line graph showing plasma concentrations (ng/ml) of sildenafil over time (hours) post dose. The curve depicts concentration rising quickly to a peak around 1-2 hours, followed by a gradual decline back near baseline by 24 hours. Data points are marked for a commercial tablet treatment.*

FDA Label Image

Figure9 (Structure)

Chemical structure diagram of sildenafil, the active ingredient in Sildenafil tablets. The structure shows various functional groups and molecular bonds characteristic to sildenafil's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.